EMA Crunch Time For Shionogi’s Novel Antibiotic Cefiderocol

 
• By Neena Brizmohun

The EU marketing application for cefiderocol that lost fast track status last July is now up for an opinion by the European Medicines Agency.

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,
A novel antibiotic is up for an opinion by the EMA • Source: Shutterstock

More from Product Reviews

More from Pink Sheet